Navigation Links
Stanford study highlights cost-effective method of lowering heart disease risks
Date:8/20/2007

g and resources becoming more strained, Stafford said case management offers many benefits, especially for health systems operated by state and local governments. "County health systems are under a particular burden because of chronic disease, and case management provides a cost-effective way of delivering improved care for those conditions," Stafford said.

San Mateo Medical Center's leaders were encouraged by the study results, and are now looking at ways of incorporating case management into their plans for revamping the county's health-care system. "These results are extremely important and timely for us as we develop ways to most effectively serve our patients with chronic diseases," said Susan Ehrlich, MD, the medical center's vice president and medical director of ambulatory services. "Our patients and staff have truly benefited from the collaboration with Stanford."

Stafford praised medical center officials for being open to exploring new health-care delivery models. "San Mateo is being very forward-thinking and willing to take some risks, and I think that reflects positively on them," Stafford said.


'/>"/>
Contact: Susan Ipaktchian
susani@stanford.edu
650-725-5375
Stanford University Medical Center
Source:Eurekalert

2

GOOD

Page: 1 2 3

Related medicine news :

1. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
2. Apollo And Stanford Team To Train Emergency Medical Technicians
3. Stanford Researchers Identify A Gene Causing Downs Syndrome
4. Transgender Experience - A Tool to Analyze Gender Difference By Stanford Scientist
5. Pharmaceutical Companies Banned from Giving Gifts at Stanford
6. Reddy Asks Stanford University to Open Hyderabad Campus
7. Gene study links endometriosis, infertility
8. Study reveals how stress can make you sick
9. Study points out that HIV vaccine may not be accepted easily
10. A new study surpasses Gene Therapy Hurdle
11. Tomato Sauce reduces Cancer Risk- Study
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 3Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 4Health News:Zogenix Increases Series B Preferred Stock Financing to $71 Million, Raising $35 Million in Second Tranche 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 3
Breaking Medicine Technology:Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Diabetes Drugs Go Head to Head in Study 62570 1Diabetes Drugs Go Head to Head in Study 62570 2Diabetes Drugs Go Head to Head in Study 62570 3Bullies May Intimidate Siblings Too 62568 1Bullies May Intimidate Siblings Too 62568 2Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 62566 1Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 62566 2